Calibrating an analyte-measurement device
CA 2543962 C · Owner: Abbott Diabetes Care Inc. · Inventors: Mcgarraugh, Geoffrey V.; Feldman, Benjamin J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration of an analyte in blood from an , "off-finger" calibration site and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 29, 2004 and granted February 21, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 29, 2024.
- Certificates of supplementary protection extend only drug patents, and it isn't classified as one.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.